Viking Therapeutics, Inc. (VKTX)

34.32 +3.62 (+11.81%) USD  |  NASDAQ  |  Jan 14, 16:00
34.59 +0.28 (+0.80%) After-Hours: 20:00
More

Viking Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Altimmune, Inc. Upgrade
Moderna, Inc. Upgrade